Peter O'Donnell, ACT's Brussels Correspondent

home / authors / peter-odonnell

Peter O'Donnell is a freelance journalist who specializes in European health affairs and is based in Brussels, Belgium.

Articles

Site Logo

Clinical Trials Caught in the Fallout From Dalli-Gate

Peter O'Donnell, ACT's Brussels Correspondent
November 5th 2012

Site Logo

Yesterday's News on Conflicts of Interest at the EMA

Peter O'Donnell, ACT's Brussels Correspondent
October 22nd 2012

Site Logo

A Time Bomb Inside the New European Rules on Clinical Trials?

Peter O'Donnell, ACT's Brussels Correspondent
September 28th 2012

Site Logo

Personalized Medicine -- Now You See it, Now You Don't

Peter O'Donnell, ACT's Brussels Correspondent
September 21st 2012

Site Logo

Can EU Countries Agree on Relative Benefit?

Peter O'Donnell, ACT's Brussels Correspondent
August 28th 2012

Site Logo

Has a Regulatory Putsch Been Overlooked in the Distractions of Summer?

Peter O'Donnell, ACT's Brussels Correspondent
August 10th 2012

Site Logo

New Hope for Academics in New Clinical Trials Regime?

Peter O'Donnell, ACT's Brussels Correspondent
July 23rd 2012

Site Logo

Confidence in the Future of EU Clinical Trials Rules

Peter O'Donnell, ACT's Brussels Correspondent
July 16th 2012

Site Logo

Is Europe's Health Research Focus Becoming Too Narrow?

Peter O'Donnell, ACT's Brussels Correspondent
June 21st 2012

Site Logo

Are CT Regulation Deficiencies a Thing of the Past?

Peter O'Donnell, ACT's Brussels Correspondent
June 6th 2012

Site Logo

A New Start to Anti-Infective Research?

Peter O'Donnell, ACT's Brussels Correspondent
May 25th 2012

Site Logo

Divergences as Europe Tightens Its Rules on Drug Withdrawals

Peter O'Donnell, ACT's Brussels Correspondent
May 9th 2012

Site Logo

Gravy for the Rich, Blame for the Poor

Peter O'Donnell, ACT's Brussels Correspondent
April 25th 2012

Site Logo

No Free Lunches for AIDS Research in Europe

Peter O'Donnell, ACT's Brussels Correspondent
April 10th 2012

Site Logo

In-Licensing On the Rise in Europe

Peter O'Donnell, ACT's Brussels Correspondent
July 29th 2009

Findings show big pharma increasingly turning to other companies for molecules to stock its pipeline.

<1
...
7891011

Latest Updated Articles

Recruiting Clinical Trial Participants: How to Balance Data and Trust
Published: November 14th 2024 | Updated: November 26th 2024
Recruiting Clinical Trial Participants: How to Balance Data and Trust
In Focus: Addressing the Health Literacy Roadblock in Patient Recruitment
Published: November 15th 2024 | Updated: November 15th 2024
In Focus: Addressing the Health Literacy Roadblock in Patient Recruitment
Enhancing Empowerment in Patient-Focused Research
Published: November 19th 2024 | Updated: November 26th 2024
Enhancing Empowerment in Patient-Focused Research
© Andrii Yalanskyi - © Andrii Yalanskyi - stock.adobe.com.
Published: November 13th 2024 | Updated: November 26th 2024
Advarra Publishes Latest Site-Sponsor-CRO Collaboration Survey Results
Peer Exchange: The Importance of Improving DE&I in Clinical Trials
Published: November 8th 2024 | Updated: November 26th 2024
Peer Exchange: The Importance of Improving DE&I in Clinical Trials
Published: October 31st 2024 | Updated: November 26th 2024
Initial IRB Submission: 7 Fundamentals of Success
© 2024 MJH Life Sciences

All rights reserved.